Heterologous COVID-19 Vaccination in Spain: A Case Study of Individual Autonomy in the Real World.

Dal-Ré, RafaelFarré, MagíLucena, M Isabel2023-05-032023-05-032022-02-05http://hdl.handle.net/10668/22346In Spain, 1.5 million essentialenAstraZenecaCOVID-19Pfizer/BioNTechadultsautonomyheterologous vaccinationmix-and-matchthrombosis with thrombocytopeniavaccinesAdultCOVID-19COVID-19 VaccinesHumansMiddle AgedSpainVaccinationVaccinesHeterologous COVID-19 Vaccination in Spain: A Case Study of Individual Autonomy in the Real World.research article35131144open access10.1016/j.jval.2021.12.0111524-4733PMC8816848http://www.valueinhealthjournal.com/article/S1098301522000146/pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816848/pdf